About

Investing in mature HealthTech companies. Accelmed is a global group of funds investing in HealthTech companies (medical device, diagnostics and digital health) across all stages. We currently invest through two separate arms: Accelmed Partners a US based lower market private equity HealthTech fund, focused on Buyout and Growth Investments in commercial HealthTech (>$10M LTM) companies.

Key facts

At-a-glance profile data

Website: accelmed.com
Type: Venture Capital
Headquarters: Israel
Funds raised: $1.0B
Portfolio companies: 4
Stages: Seed
Series A
Series B
Cheque size: $8M to $50M
Sector focus: Healthcare
Cyber Risk
Cybersecurity
IoT
Medical Device

Recent investments

Recent funding rounds Accelmed took part in
Date	Company	Round	Amount
23 Nov 2024	TailorMed	Series C	$28M
6 Jun 2021	TailorMed	Series B	$20M
19 May 2021	Cynerio	Series B	$30M
31 Oct 2019	Diagnostic Robotics	Series A	$24M
11 Jan 2016	CartiHeal	Series B	$15M
9 Jul 2012	CartiHeal	Series A	$10M
1 Feb 2012	CartiHeal	Series A	$5M

Add first review

Frequently asked

What companies has Accelmed invested in?

Accelmed has invested in TailorMed, Cynerio, Diagnostic Robotics, CartiHeal.